Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases

被引:84
|
作者
Ayhan, Ali [2 ]
Salman, Mehmet Coskun [1 ]
Velipasaoglu, Melih [1 ]
Sakinci, Mehmet [1 ]
Yuce, Kunter [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Obstet & Gynecol, TR-06100 Ankara, Turkey
[2] Baskent Univ, Fac Med, Dept Obstet & Gynecol, TR-06490 Ankara, Turkey
关键词
Ovarian granulosa cell tumors; Prognostic factors; Recurrence; Mortality; Survival; STROMAL TUMORS; COMBINATION; CISPLATIN; BLEOMYCIN; ETOPOSIDE;
D O I
10.3802/jgo.2009.20.3.158
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Ovarian granulosa cell tumors are rare malignancies with a relatively favorable prognosis. However, patients still suffer from disease-related mortality. Therefore, the prognostic factors should be clarified. The purpose of this study was to investigate the clinical and pathologic characteristics related with disease recurrence and mortality in adult type ovarian granulosa cell tumors. Methods: Eighty surgically staged patients with granulosa cell ovarian tumor treated at the Hacettepe University Hospital between 1982 and 2006 were retrospectively reviewed. Clinical and pathological characteristics were analyzed. Results: Granulosa cell ovarian tumors accounted for 4.3% of malignant ovarian neoplasms. Mean age was 47.6 years. The most common presenting symptom was abnormal uterine bleeding (53.7%). Endometrial pathology was detected in 51.2% of patients preoperatively. Seventy percent of patients were diagnosed at stage 1, and 53.8% of patients received adjuvant treatment. Mean follow-up was 67.5 months. Overall 5-year and 10-year survival was 91% and 86%, respectively. Mean survival was 147.1 months. Recurrence rate was 11.2%. In univariate analysis, advanced stage, advanced age, residual disease after surgery, and need for adjuvant treatment were associated with disease-related mortality and advanced stage disease and absence of initial staging surgery were associated with disease recurrence. However, in multivariate analysis, only initial stage was found to be a significant prognostic factor. Conclusion: Initial stage seems to be the single most important prognostic factor in ovarian granulosa cell tumors. Therefore, a comprehensive staging surgery should be attempted to document the real extent of disease and to estimate the oncologic outcome more accurately.
引用
收藏
页码:158 / 163
页数:6
相关论文
共 50 条
  • [1] <hr>Prognostic factors of adult granulosa cell tumors of the ovary: a Turkish retrospective multicenter study
    Oktar, Okan
    Korkmaz, Vakkas
    Tokalioglu, Alp
    Ozturk, Cagatayhan
    Erdogan, Ozgur
    Ucar, Yesim
    Yildirim, Hande Esra Koca
    Hanedan, Candost
    Kilic, Fatih
    Ersak, Burak
    Yalcin, Necim
    Ozmen, Fatma
    Kahraman, Alper
    Esen, Selin Aktuerk
    Bas, Sevda
    Ozdas, Emel Dogan
    Selcuk, Ilker
    Ucar, Gokhan
    Kocak, Ozgur
    Cakir, Caner
    Koc, Sevgi
    Kilic, Cigdem
    Comert, Gunsu Kimyon
    Ureyen, Isin
    Toptas, Tayfun
    Narin, Mehmet Ali
    Tasci, Tolga
    Taskin, Salih
    Boran, Nurettin
    Sanci, Muzaffer
    Kos, Fahriye Tugba
    Tekin, Ozlem Moraloglu
    Ustun, Yaprak Engin
    Ortac, Firat
    Turan, Taner
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (03)
  • [2] Adult Granulosa Cell Tumors of the Ovary: A Retrospective Study of 36 FIGO Stage I Cases with Emphasis on Prognostic Pathohistological Features
    Babarovic, Emina
    Franin, Ivan
    Klaric, Marko
    Ferrari, Ani Mihaljevic
    Karnjus-Begonja, Ruzica
    Eminovic, Senija
    Ostojic, Damjana Versa
    Vrdoljak-Mozetic, Danijela
    ANALYTICAL CELLULAR PATHOLOGY, 2018, 2018
  • [3] Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary
    Park, Jeong-Yeol
    Jin, Ke Long
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Kyu-Rae
    Kim, Young-Tak
    Nam, Joo-Hyun
    GYNECOLOGIC ONCOLOGY, 2012, 125 (01) : 80 - 86
  • [4] Recurrent granulosa cell tumors (GCTs) of the ovary: A MITO-9 retrospective study
    Mangili, Giorgia
    Sigismondi, Cristina
    Frigerio, Luigi
    Candiani, Massimo
    Savarese, Antonella
    Giorda, Giorgio
    Lauria, Rossella
    Tamberi, Stefano
    Greggi, Stefano
    Lorusso, Domenica
    GYNECOLOGIC ONCOLOGY, 2013, 130 (01) : 38 - 42
  • [5] Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study
    Lee, In Ho
    Choi, Chel Hun
    Hong, Dae Gy
    Song, Jae Yun
    Kim, Young Jae
    Kim, Kyung Tai
    Lee, Kyu Wan
    Park, Il Soo
    Bae, Duk Soo
    Kim, Tae Jin
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2011, 22 (03) : 188 - 195
  • [6] Granulosa cell tumor of the ovary - Retrospective analysis of 45 cases
    Uygun, K
    Aydiner, A
    Saip, P
    Basaran, M
    Tas, F
    Kocak, Z
    Dincer, M
    Topuz, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (05): : 517 - 521
  • [7] Adult granulosa cell tumor of the ovary: a retrospective study of 37 cases
    Ugianskiene, A.
    Grove, A.
    Soegaard-Andersen, E.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (06) : 621 - 624
  • [8] Advanced Granulosa Cell Tumors of the Ovary: A Review with a Focus on Current and Novel Therapeutic Approaches
    Salkeni, Mohamad A.
    Shin, Sarah
    Takebe, Naoko
    Stevens, Sally
    Chen, Alice
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2024, 7 (04) : 263 - 271
  • [9] Prognostic predictors and spread patterns in adult ovarian granulosa cell tumors: a multicenter long-term follow-up study of 108 patients
    Ertas, Ibrahim Egemen
    Gungorduk, Kemal
    Taskin, Salih
    Akman, Levent
    Ozdemir, Aykut
    Goklu, Rifat
    Terek, Mustafa Cosan
    Ozsaran, Aydin
    Dikmen, Yilmaz
    Yildirim, Yusuf
    Ortac, Firat
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (05) : 912 - 920
  • [10] Preserving fertility in patients with granulosa cell tumors of the ovary
    Nejkovic, L.
    Stulic, J.
    Erski, I. Rudic Biljic
    Ristic, A.
    Anicic, R.
    Vasiljevic, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (03) : 462 - 464